A Single Center, Randomized, Double-Masked, Placebo Controlled Study Evaluating the Safety and Efficacy of 0.25% PG101 and 1.0% PG101 in Subjects With Dry Eye Syndrome
Latest Information Update: 03 Feb 2016
At a glance
- Drugs PG 101 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Rhodes Pharmaceuticals
Most Recent Events
- 03 Feb 2016 New trial record